Public Good Pharma helps self-insured employers reduce specialty drug spend without cutting benefits by clinically guiding members to proven, lower-cost therapies with zero forced switches.

Transcription:

What is Public Good Pharma?

If you advise self-insured employers, you know the headache, specialty drugs. It is the one line item that ruins an otherwise perfect renewal. Public Good Pharma is your tool to fix that trend without cutting benefits. Think of us like clinical navigation for pharmacy. You already use navigators to steer members to the best surgeons for better outcomes. We do the exact same thing for drugs. We steer patients to medically proven lower cost treatments that work just as well or better than the expensive brand names. We are a biotech company that is 100% on your side. We find treatments like better dosing or generics that cost 90% less. We don't just guess. We sponsor clinical studies to prove the results. We turn wasted spending into real value.

How is Public Good Pharma different?

Now, the most important question for any broker working with employers is, is this safe and will it cause friction? We are a safe pair of hands. First, this is 100% voluntary. We never force a member to switch. We simply offer them a better choice with more support. If they say no, they stay on their current drug, zero friction. Second, we own the risk. We sponsor the study. We handle the insurance. We manage the FDA rules and safety oversight. We use top experts to validate that these treatments are likely better for the patient than standard of care. You get the savings, we handle the rest, and financially the program pays for itself. Because these drugs are so affordable, the savings cover the cost of the study, whether it's lowering the dose of a toxic cancer drug or helping people get off weight loss drugs safely, we guarantee around 20% savings immediately with a path to 90% savings long term.

Who is a good fit for Public Good Pharma?

We work best with pass through PBMs and analytics firms, at-risk payers, including self-insured employers and benefits consultants who manage plans with high spending on specialty drugs, gene therapies, or rare diseases. And while this might sound new here, this is actually a proven strategy. Major health insurers and governments around the world already conduct health economics research to identify the most cost effective therapies that can save money and improve care. We're just bringing the same safe, smart approach to the US. We make getting started easy. We start with a simple cost savings analysis to show you the potential numbers. Then we look at your past data, a retrospective study to double check everything before we ever touch a patient. Public Good Pharma puts patients and science first, partnering with you to deliver the best medicine at an affordable price.

Click here to email Savva at Public Good Pharma

3 minutes to earn 30
Watch first. Then decide.

When someone asks for time on your calendar, invite them to take the 3x3x3 Challenge to earn the meeting.